USFDA completes inspection at SMS Lifesciences’ API manufacturing facility in Telangana

09 May 2025 Evaluate

United States Food and Drug Administration (USFDA) has completed inspection at SMS Lifesciences India’s API manufacturing facility located at Sy. No. 180/2, Kazipally (V) Jinnaram MandaI, Sanga Reddy District, Telangana (Unit -1), from May 5, 2025 to May 9, 2025, with one observation. There is no impact on financial, operations or other activities of the company pursuant to the observation. 

SMS Lifesciences India is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, API and Intermediates.


Haleos Labs Share Price

1181.00 -7.05 (-0.59%)
28-Jan-2026 10:19 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.00
Dr. Reddys Lab 1227.50
Cipla 1319.55
Zydus Lifesciences 888.05
Lupin 2127.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×